Análise do uso de substâncias naturais de origem vegetal como potenciais tratamentos da artrite reumatoide: uma revisão sistemática
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease with an unknown origin. The use of
allopathic alternatives decreases inflammation and prevents damage to joint tissues, yet it presents
various adverse effects. In this regard, products derived from medicinal plants exhibit good
effectiveness and low cost, serving as promising alternatives for developing new treatment
modalities. The aim of this study is to conduct a systematic review on extracts and isolated
substances from medicinal plants used for treating rheumatoid arthritis in in vivo experimental
models. This is a systematic review conducted through searches between June 26th and 27th, 2023.
Articles published in English from January 1st, 2021, to December 31st, 2021, were searched
across the MEDLINE/PubMed, Scopus, and Web of Science platforms. As a result, 27 studies
using extracts showed positive outcomes in regulating pro-inflammatory serum cytokines involved
in RA, whereas 28 studies using isolated substances from medicinal plants displayed similar
results. Specifically, 9 extracts decreased cytokine concentration with an anti-inflammatory profile,
and 6 isolated substances demonstrated the same outcome. Lastly, 10 extracts and 5 isolated
substances led to the modulation of hematological parameters, while 20 extracts and 7 isolated
substances showed improvement in biochemical parameters. The findings suggest that the natural
substances of plant origin analyzed could potentially serve as substitutes for conventional therapy
for this pathology. However, further studies are necessary for standardizing and consolidating these
new treatments.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

